Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Part of paid clinical trials in New York, New York.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT05940272
Status
Recruiting

Conditions

  • DLBCL - Diffuse Large B Cell Lymphoma
  • Large B-cell Lymphoma
  • Large-cell Lymphoma
  • Lymphoma
  • Lymphoma, B-Cell
  • Mediastinal B-Cell Diffuse Large Cell Lymphoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Hematolo-GIST Training — BEHAVIORAL
    Hematologist will participate in a group Hematolo-GIST training provided remotely via the study team.
  • Participants Appointment — BEHAVIORAL
    Participants will meet with Hematolo-GIST trained hematologists. Participants will consent to having their appointment audio-recorded on password-protected devices or MSK approved secure platforms.

Study Details

The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.

Key Dates

Start date
Jul 3, 2023
Status verified
Oct 2025
Primary completion
Jul 3, 2028
Completion
Jul 3, 2028

Study Design

Enrollment
48 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Hematologists
    Hematologists will be recruited from the lymphoma clinics at MSK
  • Experimental: Participants Patients
    Participant patients are being treated by a hematologic oncologist participating in this study

Primary Outcome Measure

Feasibility of the Hematolo-GIST intervention among hematologists and participants [ Time Frame: Up to 1 year ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Cancer Center (All protocol activities)New YorkNew York10065
Kelly McConnell, PhD
646-888-0026
NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only)New YorkNew York10065
Alan Astrow, MD
646-962-2330

Find similar trials in New York, NY

Related Studies